| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-21 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21 |
| filingDate |
2014-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ad66f0eaf4cdc6090cfcea62f648bac |
| publicationDate |
2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2014208683-A |
| titleOfInvention |
Method for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia with minimal side effects |
| abstract |
A method and composition for treating hyperlipidemia and / or hypercholesterolemia without side effects. A method comprising administering to the subject an amount of an MTP inhibitor effective to inhibit hyperlipidemia and / or hypercholesterolemia in the subject. Administering said subject with at least three incremental doses of said MTP inhibitor to said subject. The method further includes administration of one or more other lipid modifying compounds. The MTP inhibitor is BMS-201038, and “BMS-201038” is N- (2,2,2-trifluoroethyl) -9- [4- [4-[[[4 ′-(trifluoro Methyl) [1,1′biphenyl] -2-yl] carbonyl] amino] -1-piperidinyl] butyl] 9H-fluorene-9-carboxamide, a compound known as methanesulfonate. [Selection figure] None |
| priorityDate |
2004-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |